Source: Virtual Congress 2021 – Environmental and lifestyle impacts on chronic lung disease



Rating:

Share or cite this content

Citations should be made in the following way:
E. Mortaz (Tehran, Islamic Republic of Iran), N. K. Dezfuli1 (Tehran, Islamic Republic of Iran), N. Dalil Roofchayee (Tehran, Islamic Republic of Iran), I. Adcock (Londonn, United Kingdom). Myeloid-derived suppressor cells in the blood of COVID-19 patients. 2318

Member's Comments

No comment yet.

Related content which might interest you: Peripheral blood myeloid-derived suppressor cells reflect disease status in IPF Source: ERS Lung Science Conference 2016 Year: 2016 LSC Abstract – Peripheral blood myeloid-derived suppressor cells reflect disease status in IPF Source: International Congress 2016 – New therapies and therapeutic targets Year: 2016 The emerging role of myeloid-derived suppressor cells in lung diseases Source: Eur Respir J 2016; 47: 967-977 Year: 2016 Anti-inflammatory role of myeloid-derived suppressor cells in asthma in vivo Source: International Congress 2017 – Therapeutic approaches in lung disease Year: 2017 Peripheral blood myeloid-derived suppressor cells reflect disease status in idiopathic pulmonary fibrosis Source: Eur Respir J 2016; 48: 1171-1183 Year: 2016 Galectin-9 attenuates acute lung injury in mice by inducing myeloid-derived suppressor cells Source: Annual Congress 2010 - Emerging mechanisms in lung injury Year: 2010 Induced expression of B7-H3 on the lung cancer cells and macrophages suppresses tumor-specific T cell immunity Source: Annual Congress 2012 - New aspects of lung cancer biology Year: 2012 Increase of activated/memory and decrease of naive T cells with unchanged frequency of regulatory T cells in blood of lung cancer patients Source: Annual Congress 2009 - Biological and clinical markers in lung cancer Year: 2009 Downregulation of mir-146a in peripheral blood mononuclear cells as a potential marker of NSCLC Source: Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer Year: 2020 CD4+CD25+ T regulatory cells in the peripheral blood and BAL of lung transplanted patients Source: Annual Congress 2004 - Bronchiolitis obliterans: new developments in investigating post-transplant airway disease Year: 2004 Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis in resected non–small cell lung cancer Source: Annual Congress 2009 - Pathogenesis of lung cancer Year: 2009 Myeloid derived suppressor cells in the crosstalk between COPD and lung cancer Source: Annual Congress 2011 - Immunology and cell biology of asthma and COPD Year: 2011 Suppression of HIF-1a dependent gene regulation by the tumour suppressor gene PTEN in pulmonary cells Source: Eur Respir J 2001; 18: Suppl. 33, 17s Year: 2001 T-regulatory cells in COPD or tumour environment Source: Eur Respir J 2009; 34: 284 Year: 2009 Characterisation of dendritic cells generated from peripheral blood monocytes of NSCLC patients Source: Annual Congress 2007 - Biology of thoracic malignancies Year: 2007 The ability of autologous dendritic cells to destroy NSCLC cells in vitro Source: Annual Congress 2007 - Biology in thoracic oncology Year: 2007 Tumor-infiltrating Foxp3+ regulatory T cells are correlated with cyclooxygenase-2 expression and are associated with recurrence in resected non-small cell lung cancer Source: Annual Congress 2010 - Prognostic factors for lung cancer Year: 2010 Mast cells act as partners in tumour cells metastasis to promote angiogenesis via exosomes Source: International Congress 2019 – Biology of lung cancer Year: 2019 Calcineurin inhibitors do not affect the expansion of CD4+CD25+ Treg cells in peripheral blood of lung transplant recipients Source: Eur Respir J 2006; 28: Suppl. 50, 778s Year: 2006 Human myeloid lung dendritic cells are strong inducers of T cell proliferation compared to plasmacytoid lung dendritic cells Source: Annual Congress 2005 - Basic mechanisms in asthma and COPD: new insights Year: 2005